期刊文献+

Intensive chemotherapy and sequential hematopoietic stem cell transplantation:Is it necessary for high-risk T-cell lymphoblastic lymphoma?

原文传递
导出
摘要 Adult T-cell lymphoblastic lymphoma(T-LBL)is characterized by its rarity and poor prognosis,however,it is currently being treated without any internationally recognized therapies[1].Acute lymphocytic leukemia(ALL)-like chemotherapy,such as the Berlin-Frankfurt-Muenster(BFM)regimen or the fractionated cyclophosphamide,vincristine,doxorubicin,and dexamethasone(hyperCVAD)regimen,is currently being widely used[2].
作者 Ken H.Young
出处 《Cancer Communications》 SCIE 2021年第3期273-274,共2页 癌症通讯(英文)
  • 相关文献

参考文献2

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部